These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8912578)

  • 21. [Fenofibrates and gynaecomastia].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008 May; 135(5):437. PubMed ID: 18457741
    [No Abstract]   [Full Text] [Related]  

  • 22. Does Tricor cause gallstones?
    Lee T
    Harv Heart Lett; 2008 Jul; 18(11):8. PubMed ID: 18697244
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pleiotropic effects of fibric acid derivatives (Lipanthyl-200) among patients with metabolic syndrome].
    Zvenigorodskaia LA; Mel'nikova NV; Bondarenko EIu
    Eksp Klin Gastroenterol; 2007; (1):41-6. PubMed ID: 17547112
    [No Abstract]   [Full Text] [Related]  

  • 25. A survey on the efficacy and tolerability of micronized fenofibrate in patients with dyslipidemia.
    Zhu J; Ye P
    Chin Med J (Engl); 2003 Jun; 116(6):840-3. PubMed ID: 12877791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].
    Ceska R; Stulc T
    Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination statin-fibrate therapy: safety aspects.
    Franssen R; Vergeer M; Stroes ES; Kastelein JJ
    Diabetes Obes Metab; 2009 Feb; 11(2):89-94. PubMed ID: 18518891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate-induced photosensitivity - a case series and literature review.
    Tsai KC; Yang JH; Hung SJ
    Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):213-219. PubMed ID: 28317179
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B
    J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia.
    Farnier M; Freeman MW; Macdonell G; Perevozskaya I; Davies MJ; Mitchel YB; Gumbiner B;
    Eur Heart J; 2005 May; 26(9):897-905. PubMed ID: 15781429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting vascular risk in patients with metabolic syndrome but without diabetes.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M
    Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retentive photosensitivity induced by chlorproethazine].
    Jeanmougin M; Sigal-Nahum M; Manciet JR; Petit A; Flageul B; Dubertret L
    Ann Dermatol Venereol; 1993; 120(11):840-3. PubMed ID: 8210139
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced photosensitivity reaction.
    Nedorost ST; Dijkstra JW; Handel DW
    Arch Dermatol; 1989 Mar; 125(3):433-4. PubMed ID: 2923456
    [No Abstract]   [Full Text] [Related]  

  • 38. Azapropazone therapy and photosensitivity.
    Diffey BL; Pal B; Robson J
    Photodermatol; 1986 Oct; 3(5):304-5. PubMed ID: 3822873
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myopathy caused by fenofibrate].
    Solsona L; Coll J; Ariza A; Olivé A
    Med Clin (Barc); 1991 Nov; 97(17):677. PubMed ID: 1762464
    [No Abstract]   [Full Text] [Related]  

  • 40. Photosensitivity associated with triflusal (Disgren).
    Serrano G; Aliaga A; Planells I
    Photodermatol; 1987 Apr; 4(2):103-5. PubMed ID: 3658819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.